Skip to main content

Table 1 Patient characteristics

From: Influence of oral health on frailty in patients with type 2 diabetes aged 75 years or older

 

Total (=111)

Robust (= 66)

Pre-frailty (= 33)

Frailty (= 12)

p

Sex (male), n (%)

72 (64.9%)

49 (74.2%)

18 (54.5%)

5 (41.7%)

0.032

Age (y.o.), mean±SD

79.7 ± 3.8

78.8 ± 3.1

80.7 ± 4.4

82.3 ± 3.5

0.004

BMI, mean±SD

23.2 ± 3.8

22.8 ± 3.8

23.9 ± 4.2

23.3 ± 2.5

0.336

Duration of diabetes (years), mean±SD

20.4 ± 11.1

19.7 ± 10.5

19.5 ± 10.6

26.4 ± 14.5

0.182

  ≤20 years, n (%)

57 (51.4%)

35 (53.0%)

19 (57.6%)

3 (25.0%)

0.131

  >20 years, n (%)

54 (48.6%)

31 (47.0%)

14 (42.4%)

9 (75.0%)

HbA1c (%), mean±SD

7.1 ± 0.7

7.1 ± 0.6

7.3 ± 0.9

7.2 ± 0.6

0.615

Frailty screening index, mean±SD

0.8 ± 1.1

0 ± 0

1.5 ± 0.5

3.3 ± 0.5

<0.001

OFI-8 score, mean±SD

3.9 ± 2.0

3.3 ± 1.8

4.4 ± 1.8

5.8 ± 2.4

<0.001

  Score <4, n (%)

52 (46.8%)

39 (59.1%)

11 (33.3%)

2 (16.7%)

0.003

  Score ≥4, n (%)

59 (53.2%)

27 (40.9%)

22 (66.7%)

10 (83.3%)

DASC-8, mean±SD

10.2 ± 3.0

9.2 ± 1.3

11.1 ± 3.7

13.6 ± 4.4

<0.001

  Category I, n (%)

80 (72.1%)

57 (86.4%)

19 (57.6%)

4 (33.3%)

-

  Category II, n (%)

25 (22.5%)

9 (13.6%)

11 (33.3%)

5 (41.7%)

  Category III, n (%)

6 (5.4%)

0

3 (9.1%)

3 (25.0%)

  1. DASC-8 the dementia assessment sheet for community-based integrated care system-8 items, OFI-8 score oral frailty index-8